A drug with the SMILES COc1ccc(O)c(C(=O)c2cnc3c(c2)c(-c2ccc(F)cc2)c(C#N)c(=O)n3C)c1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 12.589%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
COc1ccc(O)c(C(=O)c2cnc3c(c2)c(-c2ccc(F)cc2)c(C#N)c(=O)n3C)c1
COc1ccc(O)c(C(=O)c2cnc3c(c2)c(-c2ccc(F)cc2)c(C#N)c(=O)n3C)c1
4-(4-fluorophenyl)-6-(2-hydroxy-5-methoxybenzoyl)-1-methyl-2-oxo-1,8-naphthyridine-3-carbonitrile